Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.63
CERN's Cash to Debt is ranked lower than
77% of the 1930 Companies
in the Global Health Information Services industry.

( Industry Median: 8.51 vs. CERN: 0.63 )
Ranked among companies with meaningful Cash to Debt only.
CERN' s Cash to Debt Range Over the Past 10 Years
Min: 0.63  Med: 1.47 Max: 10.9
Current: 0.63
0.63
10.9
Equity to Asset 0.70
CERN's Equity to Asset is ranked higher than
66% of the 1831 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. CERN: 0.70 )
Ranked among companies with meaningful Equity to Asset only.
CERN' s Equity to Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.68 Max: 0.79
Current: 0.7
0.55
0.79
Interest Coverage N/A
CERN's Interest Coverage is ranked higher than
71% of the 1543 Companies
in the Global Health Information Services industry.

( Industry Median: 180.58 vs. CERN: N/A )
Ranked among companies with meaningful Interest Coverage only.
CERN' s Interest Coverage Range Over the Past 10 Years
Min: 17.1  Med: 76.09 Max: N/A
Current: N/A
F-Score: 6
Z-Score: 9.10
M-Score: -2.99
WACC vs ROIC
9.23%
15.57%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 18.99
CERN's Operating margin (%) is ranked higher than
85% of the 1869 Companies
in the Global Health Information Services industry.

( Industry Median: 4.79 vs. CERN: 18.99 )
Ranked among companies with meaningful Operating margin (%) only.
CERN' s Operating margin (%) Range Over the Past 10 Years
Min: 13.43  Med: 19.21 Max: 22.43
Current: 18.99
13.43
22.43
Net-margin (%) 13.27
CERN's Net-margin (%) is ranked higher than
80% of the 1869 Companies
in the Global Health Information Services industry.

( Industry Median: 3.13 vs. CERN: 13.27 )
Ranked among companies with meaningful Net-margin (%) only.
CERN' s Net-margin (%) Range Over the Past 10 Years
Min: 8.36  Med: 13.05 Max: 15.44
Current: 13.27
8.36
15.44
ROE (%) 15.88
CERN's ROE (%) is ranked higher than
75% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 6.06 vs. CERN: 15.88 )
Ranked among companies with meaningful ROE (%) only.
CERN' s ROE (%) Range Over the Past 10 Years
Min: 12.37  Med: 14.53 Max: 16.32
Current: 15.88
12.37
16.32
ROA (%) 11.16
CERN's ROA (%) is ranked higher than
83% of the 1936 Companies
in the Global Health Information Services industry.

( Industry Median: 2.84 vs. CERN: 11.16 )
Ranked among companies with meaningful ROA (%) only.
CERN' s ROA (%) Range Over the Past 10 Years
Min: 7.98  Med: 10.63 Max: 12.18
Current: 11.16
7.98
12.18
ROC (Joel Greenblatt) (%) 47.59
CERN's ROC (Joel Greenblatt) (%) is ranked higher than
62% of the 1896 Companies
in the Global Health Information Services industry.

( Industry Median: 22.22 vs. CERN: 47.59 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CERN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 36.87  Med: 48.76 Max: 73.16
Current: 47.59
36.87
73.16
Revenue Growth (3Y)(%) 19.10
CERN's Revenue Growth (3Y)(%) is ranked higher than
82% of the 1447 Companies
in the Global Health Information Services industry.

( Industry Median: 5.30 vs. CERN: 19.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CERN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.8  Med: 15 Max: 29.6
Current: 19.1
5.8
29.6
EBITDA Growth (3Y)(%) 20.30
CERN's EBITDA Growth (3Y)(%) is ranked higher than
71% of the 1199 Companies
in the Global Health Information Services industry.

( Industry Median: 8.40 vs. CERN: 20.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CERN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -11.9  Med: 16.6 Max: 71.1
Current: 20.3
-11.9
71.1
EPS Growth (3Y)(%) 17.90
CERN's EPS Growth (3Y)(%) is ranked higher than
65% of the 1094 Companies
in the Global Health Information Services industry.

( Industry Median: 8.20 vs. CERN: 17.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CERN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -26.3  Med: 19.9 Max: 448.5
Current: 17.9
-26.3
448.5
GuruFocus has detected 2 Warning Signs with Cerner Corp $CERN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CERN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

CERN Guru Trades in Q1 2016

Steven Cohen 16,100 sh (New)
Jim Simons 817,604 sh (+894.18%)
Paul Tudor Jones 26,880 sh (+673.30%)
Ray Dalio 83,332 sh (+162.69%)
Manning & Napier Advisors, Inc 6,935,162 sh (+45.89%)
Murray Stahl 11,167 sh (+13.24%)
Vanguard Health Care Fund 16,949,730 sh (+3.20%)
PRIMECAP Management 20,000 sh (unchged)
Jeremy Grantham Sold Out
Louis Moore Bacon Sold Out
Ron Baron Sold Out
Frank Sands 12,217,479 sh (-9.38%)
» More
Q2 2016

CERN Guru Trades in Q2 2016

George Soros 10,800 sh (New)
Joel Greenblatt 19,163 sh (New)
Manning & Napier Advisors, Inc 8,496,202 sh (+22.51%)
Vanguard Health Care Fund 16,949,730 sh (unchged)
PRIMECAP Management 20,000 sh (unchged)
Jim Simons Sold Out
Steven Cohen Sold Out
Frank Sands 11,518,519 sh (-5.72%)
Murray Stahl 9,479 sh (-15.12%)
Paul Tudor Jones 21,608 sh (-19.61%)
Ray Dalio 54,000 sh (-35.20%)
» More
Q3 2016

CERN Guru Trades in Q3 2016

Jim Simons 748,404 sh (New)
Jeremy Grantham 1,285,818 sh (New)
Paul Tudor Jones 31,283 sh (+44.78%)
PRIMECAP Management 20,000 sh (unchged)
George Soros Sold Out
Vanguard Health Care Fund 16,772,630 sh (-1.04%)
Manning & Napier Advisors, Inc 8,197,607 sh (-3.51%)
Frank Sands 10,775,077 sh (-6.45%)
Murray Stahl 8,177 sh (-13.74%)
Ray Dalio 31,900 sh (-40.93%)
Joel Greenblatt 10,926 sh (-42.98%)
» More
Q4 2016

CERN Guru Trades in Q4 2016

Third Avenue Management 408,707 sh (New)
Arnold Van Den Berg 333,386 sh (New)
Joel Greenblatt 166,304 sh (+1422.09%)
Ray Dalio 249,175 sh (+681.11%)
Jim Simons 1,252,504 sh (+67.36%)
Murray Stahl 10,397 sh (+27.15%)
Vanguard Health Care Fund 16,918,530 sh (+0.87%)
Jeremy Grantham 1,291,903 sh (+0.47%)
PRIMECAP Management 20,000 sh (unchged)
Manning & Napier Advisors, Inc 3,870,904 sh (-52.78%)
Paul Tudor Jones 12,246 sh (-60.85%)
Frank Sands 3,123,675 sh (-71.01%)
» More
» Details

Insider Trades

Latest Guru Trades with CERN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 519190    SIC: 8099
Compare:NYSE:VEEV, NAS:ATHN, NAS:MDSO, NAS:HQY, NAS:WBMD, NAS:INOV, NAS:PINC, NAS:OMCL, NYSE:EVH, NYSE:TDOC, NAS:QSII, NAS:NH, NAS:HSTM, NAS:CPSI, OTCPK:ACHI, NAS:TRHC, OTCPK:COGZF, OTCPK:TLLT, OTCPK:CNAB, OTCPK:SNBP » details
Traded in other countries:CRE.Germany, CERN.Switzerland, 0R00.UK,
Cerner Corp is a supplier of health care information technology, and offers software, professional services, medical device integration, remote hosting and employer health and wellness services.

Cerner Corp was incorporated as a Missouri Corporation in 1980, and it was merged into a Delaware corporation in 1986. The Company is a supplier of health care information technology and offers solutions and services that support the clinical, financial and operational needs of organizations. It has systems in 18,000 facilities throughout the world, including hospitals, physician practices, laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics, surgery centers, extended care facilities, retail pharmacies, and employer sites. Cerner solutions are offered on the unified Cerner Millennium architecture, a person-centric computing framework, which combines clinical, financial and management information systems. This architecture allows providers to securely access an individual's electronic health record at the point of care, and it organizes and delivers information to meet the specific needs of physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals and consumers. It has also created the Healthe IntentTM platform, a cloud-based platform that enables a new generation of solutions to leverage the increasing amount of data being captured as the health care industry is digitized. The Company also offers services, including implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs and third party administrator services for employer-based health plans. It also offers hardware and devices, both from Cerner and as a reseller for third parties. The Company's main competitors in the health care solutions and services market include Allscripts Healthcare Solutions, Inc., Computer Programs and Systems, Inc., Epic Systems Corporation, GE Healthcare Technologies, Healthcare Management Systems, Inc., Healthland, Inc. , Computer Sciences Corporation, McKesson Corporation, Medical Information Technology, Inc., Siemens Medical Solutions Health Services Corporation, and Quadramed Corporation.

Guru Investment Theses on Cerner Corp

Third Avenue Management Comments on Cerner - Feb 01, 2017

Cerner (NASDAQ:CERN) is a leading health care information technology company. We have long admired Cerner as it is a well-financed compounder, having compounded book value at an average rate of 16% over the past 10 years. Delays in customer adoption of healthcare Information Technology (IT) systems as regulatory mandates have lengthened, exacerbated by concerns about potential changes to the ACA and the impact on healthcare IT spend, have negatively pressured Cerner's common stock price down from over $67 to our initial purchase cost of approximately $48, giving us an opportunity to acquire shares of Cerner common stock at an attractive valuation.

Healthcare IT has been in the sweet spot of spending for hospitals as regulatory reform and increasingly complex regulatory requirements have driven a greater need for IT solutions. The ACA and Health Information Technology Economic and Clinical Health Act (HITECH) were established to transition the U.S. healthcare system from fee-for-service towards value-based outcomes, i.e., incentivizing hospitals and providers for increasing quality of care and patient outcomes rather than the volume of procedures performed. As part of this initiative, electronic health records systems were required and analytics and data collection to monitor outcomes is increasing. Cerner is one of the market leaders in these systems. Similar to other IT companies, services and software for the installed base of systems generates high-margin recurring revenue. Further, many legacy systems are in need of upgrades to enable them to meet the new regulatory requirements. Given its market leading position, Cerner has been gaining share and is well-positioned to continue to take share. In addition, there has been consolidation within the industry, including some vendors discontinuing products.

While uncertainty remains regarding the ultimate resolution of the ACA, we believe the benefit of increased efficiencies that enhanced IT systems provide, along with increasing use cases, e.g., population health, will continue to bode well for Cerner's business, enabling the company to grow and compound value over the longer-term.

From Third Avenue Management (Trades, Portfolio)'s fourth calendar quarter 2016 shareholder letter.

Check out Third Avenue Management,Martin Whitman latest stock trades

Top Ranked Articles about Cerner Corp

Third Avenue Management's Top 5 Stock Buys of Q4 Martin Whitman's value-focused firm updates portfolio
The firm founded by legendary investor Martin Whitman (Trades, Portfolio), Third Avenue Management (Trades, Portfolio), selected eight new stocks and its flagship value fund beat the market in the fourth quarter. Read more...
Third Avenue Management Comments on Cerner Guru stock highlight
Cerner (NASDAQ:CERN) is a leading health care information technology company. We have long admired Cerner as it is a well-financed compounder, having compounded book value at an average rate of 16% over the past 10 years. Delays in customer adoption of healthcare Information Technology (IT) systems as regulatory mandates have lengthened, exacerbated by concerns about potential changes to the ACA and the impact on healthcare IT spend, have negatively pressured Cerner's common stock price down from over $67 to our initial purchase cost of approximately $48, giving us an opportunity to acquire shares of Cerner common stock at an attractive valuation. Read more...
CEOs and CFOs Who Quote Buffett and Graham A search project of company officers who have quoted them in shareholder letters
One of my favorite activities is to read letters to shareholders from different companies across different countries. My favorite ones are of course Warren Buffett (Trades, Portfolio)’s letters. Read more...
The Moat Stays Strong, Even if the Listing Is Gone Cerner lost its place on a wide moat list but still retains its moat and has good odds for delivering double-digit growth through the next decade
In mid-September, Cerner Corp. (NASDAQ:CERN) was removed from a prestigious list: The Morningstar Wide Moat Focus IndexSM. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 30.11
CERN's P/E(ttm) is ranked lower than
58% of the 1348 Companies
in the Global Health Information Services industry.

( Industry Median: 26.07 vs. CERN: 30.11 )
Ranked among companies with meaningful P/E(ttm) only.
CERN' s P/E(ttm) Range Over the Past 10 Years
Min: 14.92  Med: 36.69 Max: 54.94
Current: 30.11
14.92
54.94
Forward P/E 22.08
CERN's Forward P/E is ranked higher than
51% of the 369 Companies
in the Global Health Information Services industry.

( Industry Median: 22.57 vs. CERN: 22.08 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 30.11
CERN's PE(NRI) is ranked lower than
58% of the 1257 Companies
in the Global Health Information Services industry.

( Industry Median: 26.10 vs. CERN: 30.11 )
Ranked among companies with meaningful PE(NRI) only.
CERN' s PE(NRI) Range Over the Past 10 Years
Min: 14.53  Med: 36.67 Max: 54.94
Current: 30.11
14.53
54.94
Price/Owner Earnings (ttm) 31.74
CERN's Price/Owner Earnings (ttm) is ranked lower than
62% of the 757 Companies
in the Global Health Information Services industry.

( Industry Median: 24.81 vs. CERN: 31.74 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
CERN' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 18.58  Med: 35.91 Max: 104.7
Current: 31.74
18.58
104.7
P/B 4.98
CERN's P/B is ranked lower than
67% of the 2031 Companies
in the Global Health Information Services industry.

( Industry Median: 3.08 vs. CERN: 4.98 )
Ranked among companies with meaningful P/B only.
CERN' s P/B Range Over the Past 10 Years
Min: 2.05  Med: 4.6 Max: 6.92
Current: 4.98
2.05
6.92
P/S 3.98
CERN's P/S is ranked lower than
65% of the 2013 Companies
in the Global Health Information Services industry.

( Industry Median: 2.47 vs. CERN: 3.98 )
Ranked among companies with meaningful P/S only.
CERN' s P/S Range Over the Past 10 Years
Min: 1.67  Med: 4.37 Max: 7.51
Current: 3.98
1.67
7.51
PFCF 49.71
CERN's PFCF is ranked lower than
75% of the 780 Companies
in the Global Health Information Services industry.

( Industry Median: 26.64 vs. CERN: 49.71 )
Ranked among companies with meaningful PFCF only.
CERN' s PFCF Range Over the Past 10 Years
Min: 21.57  Med: 48.17 Max: 1841.39
Current: 49.71
21.57
1841.39
POCF 16.52
CERN's POCF is ranked higher than
56% of the 972 Companies
in the Global Health Information Services industry.

( Industry Median: 18.99 vs. CERN: 16.52 )
Ranked among companies with meaningful POCF only.
CERN' s POCF Range Over the Past 10 Years
Min: 9.31  Med: 19.56 Max: 33.32
Current: 16.52
9.31
33.32
EV-to-EBIT 20.02
CERN's EV-to-EBIT is ranked lower than
55% of the 1323 Companies
in the Global Health Information Services industry.

( Industry Median: 18.17 vs. CERN: 20.02 )
Ranked among companies with meaningful EV-to-EBIT only.
CERN' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.1  Med: 22.8 Max: 36.7
Current: 20.02
9.1
36.7
EV-to-EBITDA 12.97
CERN's EV-to-EBITDA is ranked higher than
54% of the 1447 Companies
in the Global Health Information Services industry.

( Industry Median: 14.43 vs. CERN: 12.97 )
Ranked among companies with meaningful EV-to-EBITDA only.
CERN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.7  Med: 14.4 Max: 25.2
Current: 12.97
5.7
25.2
PEG 1.88
CERN's PEG is ranked higher than
55% of the 568 Companies
in the Global Health Information Services industry.

( Industry Median: 2.04 vs. CERN: 1.88 )
Ranked among companies with meaningful PEG only.
CERN' s PEG Range Over the Past 10 Years
Min: 0.78  Med: 2.23 Max: 3.81
Current: 1.88
0.78
3.81
Shiller P/E 51.55
CERN's Shiller P/E is ranked lower than
65% of the 292 Companies
in the Global Health Information Services industry.

( Industry Median: 38.39 vs. CERN: 51.55 )
Ranked among companies with meaningful Shiller P/E only.
CERN' s Shiller P/E Range Over the Past 10 Years
Min: 34.87  Med: 71.24 Max: 94.06
Current: 51.55
34.87
94.06
Current Ratio 1.92
CERN's Current Ratio is ranked lower than
51% of the 1798 Companies
in the Global Health Information Services industry.

( Industry Median: 1.97 vs. CERN: 1.92 )
Ranked among companies with meaningful Current Ratio only.
CERN' s Current Ratio Range Over the Past 10 Years
Min: 1.92  Med: 2.73 Max: 4.05
Current: 1.92
1.92
4.05
Quick Ratio 1.90
CERN's Quick Ratio is ranked higher than
52% of the 1798 Companies
in the Global Health Information Services industry.

( Industry Median: 1.80 vs. CERN: 1.90 )
Ranked among companies with meaningful Quick Ratio only.
CERN' s Quick Ratio Range Over the Past 10 Years
Min: 1.9  Med: 2.68 Max: 4.01
Current: 1.9
1.9
4.01
Days Inventory 8.39
CERN's Days Inventory is ranked higher than
65% of the 1085 Companies
in the Global Health Information Services industry.

( Industry Median: 17.60 vs. CERN: 8.39 )
Ranked among companies with meaningful Days Inventory only.
CERN' s Days Inventory Range Over the Past 10 Years
Min: 7.15  Med: 13.98 Max: 19.85
Current: 8.39
7.15
19.85
Days Sales Outstanding 69.69
CERN's Days Sales Outstanding is ranked lower than
52% of the 1495 Companies
in the Global Health Information Services industry.

( Industry Median: 67.15 vs. CERN: 69.69 )
Ranked among companies with meaningful Days Sales Outstanding only.
CERN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.04  Med: 80.17 Max: 102.12
Current: 69.69
66.04
102.12
Days Payable 111.56
CERN's Days Payable is ranked higher than
82% of the 1326 Companies
in the Global Health Information Services industry.

( Industry Median: 42.55 vs. CERN: 111.56 )
Ranked among companies with meaningful Days Payable only.
CERN' s Days Payable Range Over the Past 10 Years
Min: 47.89  Med: 99.82 Max: 115.48
Current: 111.56
47.89
115.48

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.90
CERN's 3-Year Average Share Buyback Ratio is ranked higher than
63% of the 1144 Companies
in the Global Health Information Services industry.

( Industry Median: -2.50 vs. CERN: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CERN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.4  Med: -1.5 Max: 0.2
Current: -0.9
-3.4
0.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 10.88
CERN's Price/Tangible Book is ranked lower than
76% of the 1695 Companies
in the Global Health Information Services industry.

( Industry Median: 4.53 vs. CERN: 10.88 )
Ranked among companies with meaningful Price/Tangible Book only.
CERN' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.79  Med: 5.63 Max: 11.3
Current: 10.88
1.79
11.3
Price/Projected FCF 2.41
CERN's Price/Projected FCF is ranked lower than
59% of the 850 Companies
in the Global Health Information Services industry.

( Industry Median: 2.03 vs. CERN: 2.41 )
Ranked among companies with meaningful Price/Projected FCF only.
CERN' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.33  Med: 2.58 Max: 4.7
Current: 2.41
1.33
4.7
Price/DCF (Earnings Based) 1.15
CERN's Price/DCF (Earnings Based) is ranked higher than
66% of the 119 Companies
in the Global Health Information Services industry.

( Industry Median: 1.45 vs. CERN: 1.15 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.91
CERN's Price/Median PS Value is ranked higher than
69% of the 1759 Companies
in the Global Health Information Services industry.

( Industry Median: 1.10 vs. CERN: 0.91 )
Ranked among companies with meaningful Price/Median PS Value only.
CERN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.35  Med: 0.73 Max: 1.54
Current: 0.91
0.35
1.54
Price/Peter Lynch Fair Value 1.88
CERN's Price/Peter Lynch Fair Value is ranked lower than
53% of the 357 Companies
in the Global Health Information Services industry.

( Industry Median: 1.79 vs. CERN: 1.88 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CERN' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.69  Med: 1.89 Max: 3.42
Current: 1.88
0.69
3.42
Price/Graham Number 3.82
CERN's Price/Graham Number is ranked lower than
67% of the 996 Companies
in the Global Health Information Services industry.

( Industry Median: 2.49 vs. CERN: 3.82 )
Ranked among companies with meaningful Price/Graham Number only.
CERN' s Price/Graham Number Range Over the Past 10 Years
Min: 1.62  Med: 3.04 Max: 13.67
Current: 3.82
1.62
13.67
Earnings Yield (Greenblatt) (%) 4.97
CERN's Earnings Yield (Greenblatt) (%) is ranked higher than
66% of the 2127 Companies
in the Global Health Information Services industry.

( Industry Median: 2.10 vs. CERN: 4.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CERN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.7  Med: 4.4 Max: 11
Current: 4.97
2.7
11
Forward Rate of Return (Yacktman) (%) 17.65
CERN's Forward Rate of Return (Yacktman) (%) is ranked higher than
70% of the 772 Companies
in the Global Health Information Services industry.

( Industry Median: 10.37 vs. CERN: 17.65 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CERN' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 1.5  Med: 17 Max: 22.8
Current: 17.65
1.5
22.8

More Statistics

Revenue (TTM) (Mil) $4,796
EPS (TTM) $ 1.84
Beta0.94
Short Percentage of Float5.98%
52-Week Range $47.01 - 67.50
Shares Outstanding (Mil)329.72

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 5,232 5,540 6,153
EPS ($) 2.53 2.73 3.05
EPS w/o NRI ($) 2.53 2.73 3.05
EPS Growth Rate
(3Y to 5Y Estimate)
17.82%
Dividends Per Share ($)
» More Articles for CERN

Headlines

Articles On GuruFocus.com
Third Avenue Management's Top 5 Stock Buys of Q4 Feb 21 2017 
Third Avenue Management Comments on Cerner Feb 01 2017 
Calendar 4th Quarter Shareholder Letter From Marty Whitman's Third Avenue Value Fund Feb 01 2017 
5 Companies Near 52-Week Lows Jan 04 2017 
4 Stocks Reach Their 3-Year Low Prices Dec 31 2016 
CEOs and CFOs Who Quote Buffett and Graham Dec 12 2016 
5 Companies for Enterprising Investors Near 52-Week Lows Dec 05 2016 
The Moat Stays Strong, Even If the Listing Is Gone Oct 24 2016 
Weekly CFO Sells Highlights Aug 23 2016 
14 Best Undervalued Stocks of the Week Aug 09 2016 

More From Other Websites
Third Avenue Management's Top 5 Stock Buys of Q4 Feb 21 2017
Stocks Our Favorite Large-Cap Managers Have Been Buying Feb 20 2017
Cerner IT support: 'We've flipped the model upside-down' Feb 17 2017
Cerner to Highlight Value-Add Delivery Services in Booth 2161 at HIMSS17 Feb 17 2017
DoD: New Cerner records system will empower patients Feb 16 2017
CERNER CORP /MO/ Financials Feb 16 2017
Behind the scenes: How Cerner protects its most valuable asset Feb 15 2017
ETFs with exposure to Cerner Corp. : February 14, 2017 Feb 14 2017
Cerner to Webcast Investment Community Meeting Feb 14 2017
Cerner Corp. :CERN-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017 Feb 13 2017
Cerner's EHR Platform to Enhance Health Care at San Juan NGO Feb 13 2017
Post Earnings Coverage as Cerner's Revenue Grew 7%; Met Expectations Feb 13 2017
Is Cerner Still A Growth Company? Feb 12 2017
The Biggest Loser: Cerner Slides 4.4% Feb 10 2017
CERNER CORP /MO/ Files SEC form 10-K, Annual Report Feb 10 2017
DoD quietly turns on Cerner's EHR pilot Feb 10 2017
Get a sneak peek inside Cerner's new Innovations Campus Feb 10 2017
[$$] Cerner Revenue Rises Feb 10 2017
Cerner (CERN) Q4 Earnings Meet, Revenues Miss Estimates Feb 10 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)